REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pro.Med.Cs Praha A.S. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pro.Med.Cs Praha A.S. Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pro.Med.Cs Praha A.S. is based in Czech Republic, with the head office in Prague. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on February 01, 1989. There are currently 500 - 999 (2023) people employed by Pro.Med.Cs Praha A.S.. There was a net sales revenue increase of 14.24% reported in Pro.Med.Cs Praha A.S.’s latest financial highlights for 2024. Its’ total assets recorded a growth of 11.88%. The enterprise’s net profit margin increased by 0.49% in 2024.

Headquarters
Telcska 377/1
Prague; The City of Prague; Postal Code: 14000

Contact Details: Purchase the Pro.Med.Cs Praha A.S. report to view the information.

Website: http://www.promed.cz

Basic Information
Total Employees:
Purchase the Pro.Med.Cs Praha A.S. report to view the information.
Registered Capital:
Purchase the Pro.Med.Cs Praha A.S. report to view the information.
Financial Auditors:
Purchase the Pro.Med.Cs Praha A.S. report to view the information.
Incorporation Date:
February 01, 1989
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
Vice Chairman of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Chairman of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Sibex Line D.O.O. Beograd (Serbia)
Company Performance
Financial values in the chart are available after Pro.Med.Cs Praha A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
14.24%▲
Total Operating Revenue
14.32%▲
Operating Profit
7.18%▲
EBITDA
7.56%▲
Net Profit/Loss for the Period
17.35%▲
Total Assets
11.88%▲
Total Equity
11.43%▲
Operating Profit Margin
-1.4%▼
Net Profit Margin
0.49%▲
Return on Equity (ROE)
0.9%▲
Quick Ratio
-1.01%▼
Cash Ratio
-0.66%▼

Similar companies

Zentiva, K.S.
 
Novartis S.R.O.
Teva Czech Industries S.R.O.
 
Novavax Cz A.S.
Hartmann - Rico A.S.
 
Lohmann & Rauscher, S.R.O.
Glenmark Pharmaceuticals S.R.O.
 
Janssen-Cilag S.R.O.
Bioveta, A.S.
 
Boehringer Ingelheim, Spol. S R.O.
Teva Pharmaceuticals Cr, S.R.O.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo